EFFECTS OF TESTOSTERONE SUPPLEMENTATION ON MARKERS OF THE METABOLIC SYNDROME AND INFLAMMATION IN HYPOGONADAL MEN WITH THE METABOLIC SYNDROME: THE DOUBLE-BLINDED PLACEBO-CONTROLLED MOSCOW STUDY Article Kalinchenko S.Y., Tishova Y.A., Mskhalaya G.J., Gooren L.J.G., Giltay E.J., Saad F. Clinical Endocrinology. Vol. 73. 2010. P. 602-612
SOMATOSTATIN RECEPTOR 2 EXPRESSION IN THE HUMAN ENDOMETRIUM THROUGH THE MENSTRUAL CYCLE Article Richmond I., Maguiness S., Robinson J., Helboe L., Adams I.P., Drummond N.S., Atkin S.L., Green V.L. Clinical Endocrinology. Vol. 56. 2002. P. 609-614
LIPIDS AND LIPOPROTEIN SUBFRACTIONS IN WOMEN WITH PCOS: RELATIONSHIP TO METABOLIC AND ENDOCRINE PARAMETERS Article Pirwany I.R., Fleming R., Greer I.A., Packard C.J., Sattar N. Clinical Endocrinology. Vol. 54. 2001. P. 447-453
THE EFFECTS OF SIX MONTHS OF TREATMENT WITH A LOW-DOSE OF CONJUGATED OESTROGENS IN MENOPAUSAL WOMEN Article Schlegel W., Petersdorf L.I., Junker R., Schulte H., Ebert C., Von Eckardstein A. Clinical Endocrinology. Vol. 51. 1999. P. 643-651
VARIATIONS IN ERYTHROCYTE ANTIOXIDANT GLUTATHIONE PEROXIDASE ACTIVITY DURING THE MENSTRUAL CYCLE Article Massafra Cosimo, De Felice Claudio, Gioia Dino, Buonocore Giuseppe Clinical Endocrinology. Vol. 49. 1998. P. 63-67